Published in Med Clin North Am on January 01, 2010
Efficacy and complications of surgery for Crohn's disease. Gastroenterol Hepatol (N Y) (2010) 0.82
New Data on the Use of Biologic Agents for Crohn's Disease and Ulcerative Colitis: Highlights from the 2009 CCFA Advances in IBD Meeting. Gastroenterol Hepatol (N Y) (2010) 0.75
A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science (2006) 27.49
Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet (2007) 19.08
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet (2010) 17.38
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature (2012) 16.13
High mobility group box 1 release from hepatocytes during ischemia and reperfusion injury is mediated by decreased histone deacetylase activity. J Biol Chem (2010) 1.79
Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort. Am J Gastroenterol (2006) 1.79
A phase I study of visilizumab, a humanized anti-CD3 monoclonal antibody, in severe steroid-refractory ulcerative colitis. Gastroenterology (2007) 1.64
Stopping immunomodulators and biologics in inflammatory bowel disease patients in remission. Inflamm Bowel Dis (2011) 1.51
Assessment of reliability and validity of IBD phenotyping within the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) IBD Genetics Consortium (IBDGC). Inflamm Bowel Dis (2007) 1.26
Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center. Ann Surg Oncol (2007) 1.21
Biologic therapy in the management of extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis (2007) 1.20
Small bowel resection rates in Crohn's disease and the indication for surgery over time: experience from a large tertiary care center. Inflamm Bowel Dis (2010) 1.11
Geriatric inflammatory bowel disease: phenotypic presentation, treatment patterns, nutritional status, outcomes, and comorbidity. Dig Dis Sci (2012) 1.10
Spontaneous rupture of hepatic artery aneurysm associated with polyarteritis nodosa. Am Surg (2010) 1.10
Relationship between proximal Crohn's disease location and disease behavior and surgery: a cross-sectional study of the IBD Genetics Consortium. Am J Gastroenterol (2012) 1.02
Mucosal IgG4 cell infiltration in ulcerative colitis is linked to disease activity and primary sclerosing cholangitis. Inflamm Bowel Dis (2013) 0.97
Five-Year Period Prevalence and Characteristics of Anemia in a Large US Inflammatory Bowel Disease Cohort. J Clin Gastroenterol (2016) 0.96
Prevention and treatment of postoperative Crohn's disease recurrence: an update for a new decade. Curr Gastroenterol Rep (2011) 0.96
Efficacy of infliximab for extraintestinal manifestations of inflammatory bowel disease. Curr Treat Options Gastroenterol (2007) 0.92
Systemic mastocytosis mimicking inflammatory bowel disease: A case report and discussion of gastrointestinal pathology in systemic mastocytosis. Am J Surg Pathol (2006) 0.90
Serum markers for necroinflammatory activity in patients with chronic viral hepatitis and normal or mildly elevated aminotransferase levels. Liver Int (2011) 0.88
Postoperative Crohn's disease: prevention and treatment. Expert Rev Gastroenterol Hepatol (2009) 0.86
Donor graft interferon regulatory factor-1 gene transfer worsens liver transplant ischemia/reperfusion injury. Surgery (2009) 0.85
Isocitrate dehydrogenase-1 is mutated in inflammatory bowel disease-associated intestinal adenocarcinoma with low-grade tubuloglandular histology but not in sporadic intestinal adenocarcinoma. Am J Surg Pathol (2014) 0.84
Segmental colitis associated with diverticulosis. Dig Dis Sci (2002) 0.84
Guidelines for medical treatment of Crohn's perianal fistulas: critical evaluation of therapeutic trials. Inflamm Bowel Dis (2015) 0.84
Impact of Obesity on the Management and Clinical Course of Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis (2015) 0.84
Phenotypic and genotypic characteristics of inflammatory bowel disease in French Canadians: comparison with a large North American repository. Am J Gastroenterol (2009) 0.83
Management of persistent gastric bleeding in a patient with Glanzmann's thrombasthenia. Am J Hematol (2008) 0.83
Silent Crohn's Disease: Asymptomatic Patients with Elevated C-reactive Protein Are at Risk for Subsequent Hospitalization. Inflamm Bowel Dis (2015) 0.82
Demographic and Clinical Predictors of High Healthcare Use in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis (2016) 0.82
The Influence of Anti-tumor Necrosis Factor Agents on Hemoglobin Levels of Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis (2015) 0.82
Radiologic testing in Crohn's disease. Inflamm Bowel Dis (2008) 0.80
Recurrent blood eosinophilia in ulcerative colitis is associated with severe disease and primary sclerosing cholangitis. Dig Dis Sci (2012) 0.80
Evaluation for postoperative recurrence of Crohn disease. Gastroenterol Clin North Am (2012) 0.79
Preventive therapy in postoperative Crohn's disease. Curr Opin Gastroenterol (2010) 0.79
Pathologic features of early inflammatory bowel disease. Gastroenterol Clin North Am (2002) 0.79
Delineation of Crohn's Disease Trajectories Using Change in Lémann Index: A Natural History Study. J Clin Gastroenterol (2016) 0.78
Postoperative management of crohn disease. Gastroenterol Clin North Am (2009) 0.78
Postoperative Crohn's disease: how can we prevent it? Expert Rev Clin Immunol (2010) 0.78
Stopping, continuing, or restarting immunomodulators and biologics when an infection or malignancy develops. Inflamm Bowel Dis (2014) 0.77
Quality of Sleep and Coexistent Psychopathology Have Significant Impact on Fatigue Burden in Patients With Inflammatory Bowel Disease. J Clin Gastroenterol (2016) 0.77
Guidelines for the multidisciplinary management of Crohn's perianal fistulas: summary statement. Inflamm Bowel Dis (2015) 0.77
Clinical course of Crohn's disease following treatment of lymphoma. Inflamm Bowel Dis (2011) 0.76
The Cost of Crohn's Disease: Varied Health Care Expenditure Patterns Across Distinct Disease Trajectories. Inflamm Bowel Dis (2016) 0.75
Lasting Impact of Clostridium difficile Infection in Inflammatory Bowel Disease: A Propensity Score Matched Analysis. Inflamm Bowel Dis (2017) 0.75
A Pilot Study of the Prevalence of Anal Human Papillomavirus and Dysplasia in a Cohort of Patients With IBD. Dis Colon Rectum (2017) 0.75
Multiyear Patterns of Serum Inflammatory Biomarkers and Risk of Colorectal Neoplasia in Patients with Ulcerative Colitis. Inflamm Bowel Dis (2016) 0.75
Ultra-high C-reactive protein levels in hospitalized inflammatory bowel disease (IBD) patients predicts serious complications. Int J Colorectal Dis (2013) 0.75
Silent Crohn's Disease Predicts Increased Bowel Damage During Multiyear Follow-up: The Consequences of Under-reporting Active Inflammation. Inflamm Bowel Dis (2016) 0.75
Telephone Encounters Predict Future High Financial Expenditures in Inflammatory Bowel Disease Patients: A 3-Year Prospective Observational Study. J Clin Gastroenterol (2017) 0.75
An unusual cause of lower gastrointestinal bleeding in Crohn's disease. Malignant infiltration with Epstein-Barr virus-positive diffuse large B-cell non-Hodgkin's lymphoma. Gastroenterology (2012) 0.75
Management of perianal fistula in Crohn's disease. Inflamm Bowel Dis (2008) 0.75
Regional Metastatic Behavior of Nonfunctional Pancreatic Neuroendocrine Tumors: Impact of Lymph Node Positivity on Survival. Pancreas (2017) 0.75